231 related articles for article (PubMed ID: 26994690)
1. Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA.
Narva S; Chitti S; Bala BR; Alvala M; Jain N; Kondapalli VG
Eur J Med Chem; 2016 May; 114():220-31. PubMed ID: 26994690
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Wang J; Tang Q; Wu C; Zhao Y; Zheng P
Bioorg Med Chem; 2016 Apr; 24(8):1749-56. PubMed ID: 26964675
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety.
Tang Q; Duan Y; Wang L; Wang M; Ouyang Y; Wang C; Mei H; Tang S; Xiong Y; Zheng P; Gong P; Zhu W
Eur J Med Chem; 2018 Jan; 143():266-275. PubMed ID: 29197731
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrrolo[2,3-b]pyridine derivatives as potential anti-tumor agents.
Wang R; Chen Y; Yang B; Yu S; Zhao X; Zhang C; Hao C; Zhao D; Cheng M
Bioorg Chem; 2020 Jan; 94():103474. PubMed ID: 31859010
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors.
Wang LX; Liu X; Xu S; Tang Q; Duan Y; Xiao Z; Zhi J; Jiang L; Zheng P; Zhu W
Eur J Med Chem; 2017 Dec; 141():538-551. PubMed ID: 29107421
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors.
Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W
Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2-c]pyridine Mannich bases.
Jose G; Suresha Kumara TH; Sowmya HBV; Sriram D; Guru Row TN; Hosamani AA; More SS; Janardhan B; Harish BG; Telkar S; Ravikumar YS
Eur J Med Chem; 2017 May; 131():275-288. PubMed ID: 28340368
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
Tang Q; Wang L; Tu Y; Zhu W; Luo R; Tu Q; Wang P; Wu C; Gong P; Zheng P
Bioorg Med Chem Lett; 2016 Apr; 26(7):1680-4. PubMed ID: 26923692
[TBL] [Abstract][Full Text] [Related]
11. Novel imidazo[4,5-b]pyridine and triaza-benzo[c]fluorene derivatives: synthesis, antiproliferative activity and DNA binding studies.
Hranjec M; Lučić B; Ratkaj I; Pavelić SK; Piantanida I; Pavelić K; Karminski-Zamola G
Eur J Med Chem; 2011 Jul; 46(7):2748-58. PubMed ID: 21524829
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6 (1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents.
Chitti S; Singireddi S; Santosh Kumar Reddy P; Trivedi P; Bobde Y; Kumar C; Rangan K; Ghosh B; Sekhar KVGC
Bioorg Med Chem Lett; 2019 Sep; 29(18):2551-2558. PubMed ID: 31420269
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II.
Shanab K; Schirmer E; Wulz E; Weissenbacher B; Lassnig S; Slanz R; Fösleitner G; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2011 May; 21(10):3117-21. PubMed ID: 21458262
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues.
Almansour AI; Arumugam N; Suresh Kumar R; Mahalingam SM; Sau S; Bianchini G; Menéndez JC; Altaf M; Ghabbour HA
Eur J Med Chem; 2017 Sep; 138():932-941. PubMed ID: 28753517
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxicity, QSAR, and intercalation study of new diindenopyridine derivatives.
Miri R; Javidnia K; Hemmateenejad B; Azarpira A; Amirghofran Z
Bioorg Med Chem; 2004 May; 12(10):2529-36. PubMed ID: 15110835
[TBL] [Abstract][Full Text] [Related]
16. Prediction of cytotoxic activity of a series of 1H-pyrrolo[2,3-b]pyridine derivatives as possible inhibitors of c-Met using molecular fingerprints.
Damghani T; Mashayekh K; Pirhadi S; Firuzi O; Sharifi S; Edraki N; Khoshneviszadeh M; Avestan MS
J Recept Signal Transduct Res; 2019 Aug; 39(4):295-303. PubMed ID: 31658862
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894
[TBL] [Abstract][Full Text] [Related]
18. SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL 6-PHENYL-1H-PYRROLO[3,4-c]PYRIDINE-1,3-DIONE DERIVATIVES.
Wojcicka A; Becan L; Junka A; Brtoszewicz M; Secewicz A; Trynda J; Wietrzyk J
Acta Pol Pharm; 2017 Mar; 74(2):435-443. PubMed ID: 29624249
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
